SG Americas Securities’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-15,074
| Closed | -$24K | – | 2949 |
|
|
2024
Q1 | $24K | Sell |
15,074
-8,652
| -36% | -$13.8K | ﹤0.01% | 2494 |
|
|
2023
Q4 | $20K | Buy |
23,726
+1,751
| +8% | +$1.48K | ﹤0.01% | 2698 |
|
|
2023
Q3 | $24K | Buy |
+21,975
| New | +$24K | ﹤0.01% | 2708 |
|
|
2023
Q2 | – | Sell |
-21,460
| Closed | -$88K | – | 3004 |
|
|
2023
Q1 | $88K | Buy |
21,460
+7,086
| +49% | +$29.1K | ﹤0.01% | 2693 |
|
|
2022
Q4 | $72K | Buy |
14,374
+3,732
| +35% | +$18.7K | ﹤0.01% | 2528 |
|
|
2022
Q3 | $139K | Sell |
10,642
-1,077
| -9% | -$14.1K | ﹤0.01% | 2324 |
|
|
2022
Q2 | $150K | Sell |
11,719
-46,441
| -80% | -$594K | ﹤0.01% | 2618 |
|
|
2022
Q1 | $887K | Sell |
58,160
-17,510
| -23% | -$267K | 0.01% | 1335 |
|
|
2021
Q4 | $1.34M | Buy |
75,670
+51,692
| +216% | +$915K | 0.01% | 1303 |
|
|
2021
Q3 | $504K | Sell |
23,978
-13,015
| -35% | -$274K | ﹤0.01% | 2301 |
|
|
2021
Q2 | $730K | Buy |
36,993
+32,677
| +757% | +$645K | ﹤0.01% | 1583 |
|
|
2021
Q1 | $125K | Sell |
4,316
-24,059
| -85% | -$697K | ﹤0.01% | 2704 |
|
|
2020
Q4 | $860K | Buy |
28,375
+16,675
| +143% | +$505K | ﹤0.01% | 1421 |
|
|
2020
Q3 | $186K | Sell |
11,700
-70,648
| -86% | -$1.12M | ﹤0.01% | 1833 |
|
|
2020
Q2 | $1.63M | Buy |
82,348
+71,842
| +684% | +$1.42M | 0.01% | 791 |
|
|
2020
Q1 | $130K | Buy |
10,506
+5,030
| +92% | +$62.2K | ﹤0.01% | 2372 |
|
|
2019
Q4 | $101K | Buy |
+5,476
| New | +$101K | ﹤0.01% | 2546 |
|